Therapeutic plasma exchange is an apheresis modality in which plasma is separated from
the blood cellular components ex vivo, discarded, and replaced with an isosmotic fluid (most …

Half of the patients with ulcerative colitis require at least one course of systemic
corticosteroids in their lifetime. Approximately 75% of these patients will also require …

1 METHODS Upon setting the Population, Intervention, Comparison, and Outcome
questions for the guidelines, the panel identified a number of topics that might be well suited …

The guideline group was selected to be representative of relevant UK-based medical and
nursing experts. Systematic literature searches were conducted between September to …

Central venous access has become invaluable in the treatment of patients with a wide array
of acute and chronic disease entities. Central venous catheters provide durable, short‐term …

Opinion Statement Approximately 5–8% of myasthenia gravis (MG) patients test positive for
antibodies against muscle-specific tyrosine kinase (MuSK) receptors. Except in extremely …

Background The majority of reports regarding general vascular access choices for apheresis
procedures argue that peripheral venous access should be considered first. However, the …

Background Therapeutic apheresis has been used in treating hematological and non‐
hematological diseases. For a successful procedure, efficient vascular access is required …

Introduction: Venous thromboembolism (VTE) is a common comorbid condition found in
sickle cell disease (SCD) and is associated with increased mortality for adults with SCD. The …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …